CDK9 recruits HUWE1 to degrade RARα and offers therapeutic opportunities for cutaneous T-cell lymphoma

CDK9 recruits HUWE1 to degrade RARα and offers therapeutic opportunities for cutaneous T-cell lymphoma

Abstract Cutaneous T-cell lymphoma (CTCL) is a heterogeneous non-Hodgkin lymphoma originating in the skin and invading the systemic hematopoietic system. Current treatments, including chemotherapy and monoclonal antibodies yielded limited responses with high incidence of side effects, highlighting t...

Full description

Saved in:
Bibliographic Details
Main Authors: Chen-Hui Luo, Li-Hong Hu, Jie-Yang Liu, Li Xia, Li Zhou, Ren-Hong Sun, Chen-Cen Lin, Xing Qiu, Biao Jiang, Meng-Ying Yang, Xue-Hong Zhang, Xiao-Bao Yang, Guo-Qiang Chen, Ying Lu
Format: Article
Language:English
Published: Nature Portfolio 2024-12-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-024-54354-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41467-024-54354-3

Similar Items